Koninklijke Philips (PHG) Liabilities and Shareholders Equity (2009 - 2026)

Koninklijke Philips' (PHG) quarterly Liabilities and Shareholders Equity came in at $31.9 billion in Q1 2026, up 11.71% year-on-year from $28.6 billion in Q1 2025, and up 1.78% quarter-over-quarter from $31.4 billion in Q4 2025.

Koninklijke Philips (PHG) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

Koninklijke Philips' Liabilities and Shareholders Equity history runs 18 years deep, the most recent figure standing at $31.9 billion for Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 11.71% year-over-year to $31.9 billion in Q1 2026; TTM through Mar 2026 was $123.9 billion, a 35.78% increase from a year earlier, with the FY2025 full-year figure at $31.4 billion, up 1.29% from the prior year.
  • Liabilities and Shareholders Equity advanced to $31.9 billion in Q1 2026 per PHG's latest filing, from $31.4 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $34.7 billion in Q2 2022 and bottomed at $28.6 billion in Q1 2025.
  • The 5-year median for Liabilities and Shareholders Equity is $31.4 billion (2025), against an average of $31.4 billion.
  • Across the five-year window, Liabilities and Shareholders Equity decreased 11.6% in 2022 and grew 11.71% in 2026, its largest moves.
  • Year by year, Liabilities and Shareholders Equity stood at $31.3 billion in 2022, then climbed by 1.05% to $31.6 billion in 2023, then retreated by 2.13% to $31.0 billion in 2024, then gained by 1.29% to $31.4 billion in 2025, then gained by 1.78% to $31.9 billion in 2026.
  • Per Business Quant, the three latest PHG Liabilities and Shareholders Equity figures stand at $31.9 billion (Q1 2026), $31.4 billion (Q4 2025), and $30.8 billion (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 110.43 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 46.29 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 13.32 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 6.63 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 31.92 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 37.13 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 10.46 Bn
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn 10.74 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 31.92 Bn
Dec 31, 2025 31.36 Bn
Sep 30, 2025 30.79 Bn
Jun 30, 2025 29.86 Bn
Mar 31, 2025 28.58 Bn
Dec 31, 2024 30.96 Bn
Jun 30, 2024 31.74 Bn
Dec 31, 2023 31.64 Bn
Jun 30, 2023 32.13 Bn
Dec 31, 2022 31.31 Bn
Jun 30, 2022 34.67 Bn
Dec 31, 2021 35.42 Bn
Jun 30, 2021 34.93 Bn
Dec 31, 2020 33.04 Bn
Jun 30, 2020 30.27 Bn
Dec 31, 2019 29.90 Bn
Jun 30, 2019 29.61 Bn
Dec 31, 2018 29.70 Bn
Jun 30, 2018 29.63 Bn
Dec 31, 2017 29.81 Bn